[Pseudomonas aeruginosa infection]

Nihon Rinsho. 2003 Feb:61 Suppl 2:423-7.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • 4-Quinolones
  • Anti-Infective Agents / therapeutic use
  • Bacteremia
  • Biofilms
  • Carbapenems / therapeutic use
  • Cephalosporins / therapeutic use
  • Fimbriae, Bacterial
  • Flagella
  • Humans
  • Immunocompromised Host
  • Multidrug Resistance-Associated Proteins
  • Prognosis
  • Pseudomonas Infections* / diagnosis
  • Pseudomonas Infections* / drug therapy
  • Pseudomonas Infections* / microbiology
  • Pseudomonas aeruginosa / genetics
  • Pseudomonas aeruginosa / pathogenicity*
  • Respiratory Tract Infections
  • Sepsis
  • Trans-Activators
  • Urinary Tract Infections

Substances

  • 4-Quinolones
  • Anti-Infective Agents
  • Carbapenems
  • Cephalosporins
  • Multidrug Resistance-Associated Proteins
  • Trans-Activators